Both in Pharmaceuticals
Viatris vs Royalty Pharma
Over the past year VTRS returned +83.2% and RPRX returned +78.5%; their daily moves had a correlation of 0.34.
VTRS +83.2% RPRX +78.5%Growth of $1, one year, split-adjusted
| Metric | VTRS | RPRX |
|---|---|---|
| Price | $19.22 | $67.56 |
| Market cap | $22.08B | $30.08B |
| Today | +1.59% | +1.75% |
| 1 month | +9.6% | +19.7% |
| 6 months | +20.5% | +33.2% |
| Year to date | +54.4% | +74.8% |
| 1 year | +82.5% | +81.1% |
| Revenue growth (YoY) | +4.9% | +16.5% |
| Gross margin | 38.8% | 100.0% |
| Net margin | −3.2% | 2.7% |
| P/E (TTM) | — | 36.9× |
| Price / sales | 1.5× | 11.9× |
| Net cash | -$12.46B | -$8.23B |
| Dividend yield | 2.50% | 1.39% |
| Volatility (60d) | 23.4% | 24.8% |
| Short % of float | 3.3% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).